| Coler Drug Athens, Ltd | |
| 310 W Union St, Ste 101, Athens, Ohio 45701 | |
| (740) 447-9201 |
| Name | Coler Drug Athens, Ltd |
|---|---|
| Organization Name | Coler Drug Athens, Ltd |
| Location | 310 W Union St, Ste 101, Athens, Ohio 45701 |
| Type | Pharmacy |
| Phone | (740) 447-9201 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The U.S. Food and Drug Administration (FDA) has awarded $4.9 million in grant funding to institutions in a research consortium based at the Rutgers University School of Engineering to support the introduction of continuous manufacturing techniques for pharmaceuticals.
Women suffering from anorexia or bulimia draw themselves with prominently different characteristics than women who do not have eating disorders and who are considered of normal weight. This has been revealed in a new joint study from the University of Haifa, Soroka University Medical Center and Achva Academic College, Israel, published in The Arts in Psychotherapy.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
VOA News examines the 2009 HIV/AIDS Implementers Meeting in Windhoek, Namibia, which recently brought together 1,500 people from 55 countries to compare notes on HIV/AIDS programs around the world. The article features comments by Assistant U.S. Global AIDS Coordinator Michele Moloney-Kitts who attended and shared some of her experiences from the meeting.
› Verified 6 days ago
| NPI Number | 1366947111 |
| Organization Name | COLER DRUG ATHENS LTD |
| Doing Business As | SHRIVERS PHARMACY AND WELLNESS |
| Type | Pharmacy |
| Address | 310 W Union St Ste 101, Athens, OH 45701 |
| Phone Number | 740-452-7685 |
News Archive
The U.S. Food and Drug Administration (FDA) has awarded $4.9 million in grant funding to institutions in a research consortium based at the Rutgers University School of Engineering to support the introduction of continuous manufacturing techniques for pharmaceuticals.
Women suffering from anorexia or bulimia draw themselves with prominently different characteristics than women who do not have eating disorders and who are considered of normal weight. This has been revealed in a new joint study from the University of Haifa, Soroka University Medical Center and Achva Academic College, Israel, published in The Arts in Psychotherapy.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
VOA News examines the 2009 HIV/AIDS Implementers Meeting in Windhoek, Namibia, which recently brought together 1,500 people from 55 countries to compare notes on HIV/AIDS programs around the world. The article features comments by Assistant U.S. Global AIDS Coordinator Michele Moloney-Kitts who attended and shared some of her experiences from the meeting.
› Verified 6 days ago
News Archive
The U.S. Food and Drug Administration (FDA) has awarded $4.9 million in grant funding to institutions in a research consortium based at the Rutgers University School of Engineering to support the introduction of continuous manufacturing techniques for pharmaceuticals.
Women suffering from anorexia or bulimia draw themselves with prominently different characteristics than women who do not have eating disorders and who are considered of normal weight. This has been revealed in a new joint study from the University of Haifa, Soroka University Medical Center and Achva Academic College, Israel, published in The Arts in Psychotherapy.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
VOA News examines the 2009 HIV/AIDS Implementers Meeting in Windhoek, Namibia, which recently brought together 1,500 people from 55 countries to compare notes on HIV/AIDS programs around the world. The article features comments by Assistant U.S. Global AIDS Coordinator Michele Moloney-Kitts who attended and shared some of her experiences from the meeting.
› Verified 6 days ago
Cvs Pharmacy #06184 Type: Community/Retail Pharmacy Location: 555 E State St, Athens, Ohio 45701 Phone: (740) 593-8501 | |
Cvs Pharmacy #06193 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 32 S Court St, Athens, Ohio 45701 Phone: (740) 592-6024 | |
Kroger Pharmacy #901 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 919 E State St, Athens, Ohio 45701 Phone: (740) 566-4180 | |
Walmart Pharmacy 10-3486 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 929 E State St, Athens, Ohio 45701 Phone: (740) 594-3628 | |
Coler Drug Athens, Ltd Type: Pharmacy Location: 310 W Union St, Athens, Ohio 45701 Phone: (740) 447-9201 |